Parabolic Drugs Ltd - IPO

Parabolic Drugs Ltd IPO Details

Public Issue of 26,666,667 equity shares of face value Rs. 10 each (The Equity Shares) of Parabolic Drugs Limited (The Company or The Issuer) for cash at a price of Rs. 75 per equity share (including a share premium of Rs. 65 per equity share) aggregating to up to Rs. 200.00 crores (The Issue). The issue comprises a net issue of 26,166,667 equity shares and a reservation of 500,000 equity shares for subscription by eligible employees (The Employee Reservation Portion). The issue comprises a fresh issue of 24,640,965 equity shares by the company and an offer for sale of 2,025,702 equity shares by BTS India Private Equity Fund Limited and Alden Global Mauritius Limited (together, the Selling Shareholders). The Issue will constitute 43.09% of the fully diluted post issue paid-up capital of the company.Issue Price: Rs. 75 per equity share of face value of Rs. 10 each.The issue price is 7.5 times of the face value

Objective of issue

Multi-purpose block III. Sterile Cephalosporin Plant. Establishment of Chachrauli Plant. Investment in our subsidiary. Repayment / Prepayment of identified loan facilit.. General corporate purposes.

Parabolic Drugs Ltd Contact Details

Parabolic Drugs Ltd, C-13 Pannalal Silk, Mills Cmpd LBS Marg, Bhandup West, Mumbai - 400 078

Phone - 91-022-25963838

Fax - 91-022-25946969

Email - pdl.investors@parabolicdrugs.com

Website - www.parabolicdrugs.com